PL414266A1 - Concentration of selenium in blood as a risk factor for cancers in women - Google Patents
Concentration of selenium in blood as a risk factor for cancers in womenInfo
- Publication number
- PL414266A1 PL414266A1 PL414266A PL41426615A PL414266A1 PL 414266 A1 PL414266 A1 PL 414266A1 PL 414266 A PL414266 A PL 414266A PL 41426615 A PL41426615 A PL 41426615A PL 414266 A1 PL414266 A1 PL 414266A1
- Authority
- PL
- Poland
- Prior art keywords
- concentration
- selenium
- cancers
- women
- blood
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Sposób określania ryzyka raka, charakteryzuje się tym, że obejmuje ocenę stężenia selenu w próbce biologicznej badanej kobiety, przy czym stężenie selenu wskazuje znacząco zwiększone lub zmniejszone ryzyko rozwoju raków oraz uznaje się, że ryzyko raków: przy stężeniu selenu w surowicy ? 70 µg/l (lub stężeniu w dowolnym materiale biologicznym odpowiadającym stężeniu w surowicy) jest podwyższone, zaś przy stężeniu selenu w surowicy 70 - 90 µg/l (lub stężeniu w dowolnym materiale biologicznym odpowiadającym stężeniu w surowicy) jest obniżone.The method of determining the risk of cancer is characterized in that it includes the assessment of the selenium concentration in the biological sample of the examined woman, with the selenium concentration indicating a significantly increased or reduced risk of developing cancers and it is recognized that the risk of cancer: at serum selenium concentration? 70 µg / l (or the concentration in any biological material corresponding to the serum concentration) is increased, and at a serum selenium concentration 70 - 90 µg / l (or the concentration in any biological material corresponding to the serum concentration) is reduced.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL414266A PL414266A1 (en) | 2015-10-05 | 2015-10-05 | Concentration of selenium in blood as a risk factor for cancers in women |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL414266A PL414266A1 (en) | 2015-10-05 | 2015-10-05 | Concentration of selenium in blood as a risk factor for cancers in women |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL414266A1 true PL414266A1 (en) | 2017-04-10 |
Family
ID=58463572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL414266A PL414266A1 (en) | 2015-10-05 | 2015-10-05 | Concentration of selenium in blood as a risk factor for cancers in women |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL414266A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL422751A1 (en) * | 2017-09-05 | 2019-03-11 | Read-Gene Spółka Akcyjna | Method for determining the risk of cancers in women, depending on their age and concentration of chosen microelements |
-
2015
- 2015-10-05 PL PL414266A patent/PL414266A1/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL422751A1 (en) * | 2017-09-05 | 2019-03-11 | Read-Gene Spółka Akcyjna | Method for determining the risk of cancers in women, depending on their age and concentration of chosen microelements |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX389083B (en) | Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging. | |
| CL2019002264A1 (en) | Radiolabeled anti-lag3 antibodies for immuno-pet imaging. | |
| MX383381B (en) | METHODS AND COMPOSITIONS FOR DETECTING MISFOLDED PROTEINS. | |
| EP4273551A3 (en) | Multiplexed total antibody and antibody-conjugated drug quantification assay | |
| MX384485B (en) | EARLY DETECTION OF PREECLAMPSIA. | |
| MX2015015023A (en) | Method for determining free copper. | |
| NZ720608A (en) | Β-glucan assay methods | |
| PL414266A1 (en) | Concentration of selenium in blood as a risk factor for cancers in women | |
| PL414265A1 (en) | Concentration of copper in blood as a risk factor for extramammary breast cancers in women | |
| PL415634A1 (en) | Concentration of selenium in blood as a risk factor for cancers in men | |
| PL439315A1 (en) | The method of determining the risk of cancer in women depending on the concentration of selenium in the blood | |
| PL415644A1 (en) | Concentration of iron in blood as a risk factor for cancers in women after the age of 50 | |
| PL415640A1 (en) | Concentration of iron in blood and changes within HFE gene as risk factors for cancers in women | |
| PL415636A1 (en) | Concentration of iron in blood as a risk factor for cancers in men | |
| PL415632A1 (en) | Concentration in blood and changes within IL6 gene as risk factors for cancers in women | |
| PL439313A1 (en) | Method for determining the risk of cancers in women, depending on concentration of arsenic in the blood | |
| PL415643A1 (en) | Concentration of iron in blood and changes within GPX1 gene as risk factors for cancers in women | |
| PL414267A1 (en) | Concentration of iron in blood as a risk factor for cancers in women who are carriers of a mutation in BRCA1 gene | |
| PL415646A1 (en) | Concentration of copper in blood and changes within CAT gene as risk factors for cancers in women | |
| PL407244A1 (en) | Electrochemical bio-sensor for detecting S100B protein | |
| PL415645A1 (en) | Concentration of zinc in blood and changes within MMP1 gene as risk factors for cancers in women | |
| PL415639A1 (en) | Concentration of iron in blood and changes within SEP15 gene as risk factors for cancers in women | |
| PL439314A1 (en) | Method for determining the risk of cancers in women, depending on concentration of cadmium in the blood | |
| PL414268A1 (en) | Concentration of zinc in blood within IL6 gene as risk factors for cancers in women | |
| PL439317A1 (en) | Method for determining the risk of cancers in women, depending on concentration of arsenic in the blood of women who are carriers of the most common BRCA1 and BRCA2 gene mutations |